Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

3:58pm IST
Change (% chg)

Rs-23.90 (-4.04%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for SUN.NS


Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New... (more)


Beta: 0.29
Market Cap(Mil.): Rs1,542,264.00
Shares Outstanding(Mil.): 2,399.29
Dividend: 1.00
Yield (%): 0.16


  SUN.NS Industry Sector
P/E (TTM): 20.81 29.41 30.38
EPS (TTM): 30.89 -- --
ROI: -- 13.85 13.36
ROE: -- 14.79 14.50

India's Sun Pharma fourth-quarter profit down 13.6 pct

MUMBAI, May 26 Sun Pharmaceutical Industries Ltd , India's largest drugmaker by sales, reported a 13.6 percent drop in its fourth-quarter profit due to slow sales in the United States.

5:02pm IST

BRIEF-India's Sun Pharmaceutical Industries March-qtr consol profit down about 14 pct

* Consensus forecast for March quarter consol profit was 14.95 billion rupees

4:59pm IST

BRIEF-Sun Pharma announces fda filing acceptance of Biologics License Application for tildrakizumab

* Sun Pharma announces U.S. FDA filing acceptance of Biologics License Application (bla) for tildrakizumab Source text for Eikon: Further company coverage:

24 May 2017

BRIEF-Sun Pharma says US FDA files acceptance of BLA for Tildrakizumab

* Says US FDA filing acceptance of biologics license application (BLA) for Tildrakizumab

24 May 2017

BUZZ-Taro Pharmaceutical: Shares down after Q4 revenue miss

** Generic drug maker's shares fall as much as 5.9 pct to $105.70; biggest intraday pct drop in more than 5 months

23 May 2017

Sensex ends lower; healthcare stocks drag

Indian shares ended lower on Tuesday, dragged down by healthcare stocks and as investors booked profit in recent outperformers such as ITC Ltd.

23 May 2017

BUZZ-India's Sun Pharma falls to 6-mth low on Taro's weak results

** Sun Pharmaceutical Industries falls as much as 6 pct to 601.500 rupees to its lowest since Nov. 9

23 May 2017

BRIEF-Sun Pharma says filing of tildrakizumab with European Medicines Agency by Almirall

* Says validation of regulatory filing of tildrakizumab with the european medicines agency (EMA) by Almirall.

24 Mar 2017

BRIEF-Sun Pharma Industries says Canadian unit to acquire Thallion Pharma

* Taro Pharmaceuticals Inc. (Canada) entered into deal to acquire all issued and outstanding shares of Thallion Pharma

17 Mar 2017

India's Sun Pharma says U.S. FDA to lift ban on Mohali plant exports

MUMBAI India's largest drugmaker Sun Pharmaceutical Industries said U.S. regulators plan to lift a ban on its Mohali plant in northern India, paving the way for a resumption of exports to the company's biggest market after four years.

14 Mar 2017

More From Around the Web

Earnings vs. Estimates